5-HT6receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
5-HT6receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia
Authors
Keywords
-
Journal
EMBO Molecular Medicine
Volume 4, Issue 10, Pages 1043-1056
Publisher
EMBO
Online
2012-10-02
DOI
10.1002/emmm.201201410
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
- (2012) Mark J. Millan et al. NATURE REVIEWS DRUG DISCOVERY
- Animal models of schizophrenia
- (2011) CA Jones et al. BRITISH JOURNAL OF PHARMACOLOGY
- 5-HT6 receptor and cognition
- (2011) Xabier Codony et al. CURRENT OPINION IN PHARMACOLOGY
- Mutations causing syndromic autism define an axis of synaptic pathophysiology
- (2011) Benjamin D. Auerbach et al. NATURE
- Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA–induced dyskinesia
- (2011) Srinivasa Subramaniam et al. NATURE NEUROSCIENCE
- Influence of social isolation in the rat on serotonergic function and memory – Relevance to models of schizophrenia and the role of 5-HT6 receptors
- (2011) Charles A. Marsden et al. NEUROPHARMACOLOGY
- The Complexes of Mammalian Target of Rapamycin
- (2010) Hongyu Zhou et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Tti1 and Tel2 Are Critical Factors in Mammalian Target of Rapamycin Complex Assembly
- (2010) Takeshi Kaizuka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rethinking schizophrenia
- (2010) Thomas R. Insel NATURE
- Huntington’s Disease is a disorder of the corpus striatum: Focus on Rhes (Ras homologue enriched in the striatum)
- (2010) Srinivasa Subramaniam et al. NEUROPHARMACOLOGY
- Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders
- (2010) Dan Ehninger et al. TRENDS IN MOLECULAR MEDICINE
- mTORC1 signaling: what we still don't know
- (2010) X. Wang et al. Journal of Molecular Cell Biology
- Inhibition of mTOR Signaling in Parkinson's Disease Prevents L-DOPA-Induced Dyskinesia
- (2009) E. Santini et al. Science Signaling
- Effects of 5-HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat
- (2008) B Marcos et al. BRITISH JOURNAL OF PHARMACOLOGY
- Reversal of learning deficits in a Tsc2 +/− mouse model of tuberous sclerosis
- (2008) Dan Ehninger et al. NATURE MEDICINE
- Behavioural and neurochemical effects of post-weaning social isolation in rodents—Relevance to developmental neuropsychiatric disorders
- (2008) Kevin C.F. Fone et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions
- (2008) M MILLAN et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Role of mTOR in physiology and pathology of the nervous system
- (2007) Lukasz Swiech et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now